Medical - Instruments

搜索文档
Mettler-Toledo (MTD) Q2 Earnings and Revenues Top Estimates
ZACKS· 2025-08-01 06:46
Mettler-Toledo (MTD) came out with quarterly earnings of $10.09 per share, beating the Zacks Consensus Estimate of $9.58 per share. This compares to earnings of $9.65 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +5.32%. A quarter ago, it was expected that this maker of precision instruments would post earnings of $7.9 per share when it actually produced earnings of $8.19, delivering a surprise of +3.67%.Over the last four q ...
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates
ZACKS· 2025-07-31 23:31
Envoy Medical, Inc. (COCH) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.27 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10.34%. A quarter ago, it was expected that this company would post a loss of $0.35 per share when it actually produced a loss of $0.29, delivering a surprise of +17.14%.Over the last four quarters, the company has ...
Teleflex (TFX) Q2 Earnings and Revenues Top Estimates
ZACKS· 2025-07-31 20:45
Teleflex (TFX) came out with quarterly earnings of $3.73 per share, beating the Zacks Consensus Estimate of $3.36 per share. This compares to earnings of $3.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +11.01%. A quarter ago, it was expected that this medical equipment maker would post earnings of $2.88 per share when it actually produced earnings of $2.91, delivering a surprise of +1.04%.Over the last four quarters, the ...
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
ZACKS· 2025-07-31 20:11
Integra LifeSciences (IART) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.63 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +4.65%. A quarter ago, it was expected that this medical device maker would post earnings of $0.43 per share when it actually produced earnings of $0.41, delivering a surprise of -4.65%.Over the last four quar ...
DexCom (DXCM) Q2 Earnings and Revenues Top Estimates
ZACKS· 2025-07-31 06:16
公司业绩表现 - 季度每股收益0 48美元 超出市场预期的0 45美元 同比增长11 63% [1] - 季度营收11 6亿美元 超出市场预期3 06% 同比增长16% [2] - 过去四个季度中 公司两次超出每股收益预期 四次超出营收预期 [2] 市场反应与股价表现 - 本季度业绩超预期幅度达6 67% 而上一季度低于预期3 03% [1] - 年初至今股价累计上涨14 9% 跑赢标普500指数8 3%的涨幅 [3] - 当前Zacks评级为2级(买入) 预计短期内将跑赢大盘 [6] 未来业绩展望 - 下季度预期每股收益0 57美元 营收11 8亿美元 [7] - 当前财年预期每股收益2 03美元 营收46 1亿美元 [7] - 业绩电话会议的管理层评论将影响股价短期走势 [3] 行业比较 - 所属医疗仪器行业在Zacks行业排名中处于后35% [8] - 同业公司Tactile Systems Technology预计下季度每股收益0 09美元 同比下滑55% [9] - Tactile Systems Technology预计季度营收7379万美元 同比微增0 8% [10]
Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates
ZACKS· 2025-07-31 06:11
Hologic (HOLX) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.86%. A quarter ago, it was expected that this medical device maker would post earnings of $1.02 per share when it actually produced earnings of $1.03, delivering a surprise of +0.98%.Over the last four quarters, the com ...
Steris (STE) Earnings Expected to Grow: Should You Buy?
ZACKS· 2025-07-30 23:07
The market expects Steris (STE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on August 6, might help the stock move higher if these key numbers are better than ex ...
Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights
ZACKS· 2025-07-30 07:16
Pacific Biosciences of California (PACB) closed at $1.54 in the latest trading session, marking a -6.1% move from the prior day. This change lagged the S&P 500's daily loss of 0.3%. Elsewhere, the Dow saw a downswing of 0.46%, while the tech-heavy Nasdaq depreciated by 0.38%. Heading into today, shares of the maker of genetic analysis technology had gained 32.26% over the past month, outpacing the Medical sector's gain of 0.76% and the S&P 500's gain of 3.64%.Investors will be eagerly watching for the perfo ...
Penumbra (PEN) Surpasses Q2 Earnings and Revenue Estimates
ZACKS· 2025-07-30 06:21
Penumbra (PEN) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.64 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +6.17%. A quarter ago, it was expected that this medical device maker would post earnings of $0.66 per share when it actually produced earnings of $0.83, delivering a surprise of +25.76%.Over the last four quarters, the co ...
Is the Options Market Predicting a Spike in Fresenius Medical Stock?
ZACKS· 2025-07-29 21:51
Investors in Fresenius Medical Care AG (FMS) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $12.50 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It co ...